USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 141 followers.

USP18 expression as a predictor of treatment outcome in HCV https://t.co/Wr7J5wTX3P

Reply Repost Favourite

USP18 expression as a predictor of treatment outcome in HCV https://t.co/hF38K7ml2N

Reply Repost Favourite

USP18 expression as a predictor of treatment outcome in HCV https://t.co/d1DJZBETZ1

Reply Repost Favourite